+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

T2 Biosystems Inc (TTOO) - Product Pipeline Analysis, 2019 Update

  • ID: 1945420
  • Company Profile
  • August 2019
  • 40 pages
  • GlobalData

FEATURED COMPANIES

  • Becton Dickinson and Co
  • BioFire Diagnostics Inc
  • Celula Inc
  • Diadexus Inc
  • GenMark Diagnostics Inc
  • OpGen Inc
  • MORE
Summary

T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company’s products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians' offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company T2 Biosystems Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Becton Dickinson and Co
  • BioFire Diagnostics Inc
  • Celula Inc
  • Diadexus Inc
  • GenMark Diagnostics Inc
  • OpGen Inc
  • MORE
T2 Biosystems Inc Company Overview
  • T2 Biosystems Inc Company Snapshot
  • T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
  • T2 Biosystems Inc – Pipeline Analysis Overview
  • T2 Biosystems Inc - Key Facts
  • T2 Biosystems Inc - Major Products and Services
  • T2 Biosystems Inc Pipeline Products by Development Stage
  • T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
  • T2 Biosystems Inc Pipeline Products Overview
  • T2Carba Resistance+
  • T2Carba Resistance+ Product Overview
  • T2Dx - Cancer
  • T2Dx - Cancer Product Overview
  • T2Dx - Cardiac
  • T2Dx - Cardiac Product Overview
  • T2Endotoxin
  • T2Endotoxin Product Overview
  • T2HemoStat
  • T2HemoStat Product Overview
  • T2Lyme Panel
  • T2Lyme Panel Product Overview
  • T2Lyme Panel Clinical Trial
  • T2MR Assay - Platelet Function Testing
  • T2MR Assay - Platelet Function Testing Product Overview
  • T2Plex
  • T2Plex Product Overview
  • T2Resistance Panel
  • T2Resistance Panel Product Overview
  • T2Resistance Panel - Expansion
  • T2Resistance Panel - Expansion Product Overview
  • T2 Biosystems Inc - Key Competitors
  • T2 Biosystems Inc - Key Employees
  • T2 Biosystems Inc - Key Employee Biographies
  • T2 Biosystems Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Recent Developments
  • T2 Biosystems Inc, Recent Developments
  • Aug 16, 2019: T2 Biosystems expands access to its innovative rapid diagnostic technologies to Australia, Fiji and New Zealand
  • Aug 06, 2019: T2Bacteria Panel is the first and only in-vitro diagnostic test to receive approval for a new technology add-on payment by CMS
  • Jul 30, 2019: T2 Biosystems reports second quarter 2019 financial results and provides corporate update
  • Jul 29, 2019: T2 Biosystems to offer diagnostic panels in new markets
  • Jun 28, 2019: T2 Biosystems named one of the fastest-growing companies in Massachusetts
  • Jun 20, 2019: T2 Biosystems introduces new clinical data and updates regarding expanding capabilities of its rapid diagnostic technology at ASM Microbe 2019
  • Jun 17, 2019: T2 Biosystems highlights current and future opportunities for its breakthrough rapid diagnostic technology for biothreat pathogen detection
  • Jun 12, 2019: T2 Biosystems to highlight its products and technology at Upcoming Medical Meetings
  • Jun 06, 2019: New studies highlight potential for T2Bacteria and T2Candida panels to improve outcomes and be cost-effective for sepsis patients in the Medical Intensive Care Unit and Emergency Department
  • May 24, 2019: T2 Biosystems to participate in Singular Research Spring Select Web Call
Appendix
  • Methodology
  • About the Author
  • Contact Us
  • Disclaimer
List of Tables
  • T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
  • T2 Biosystems Inc Pipeline Products by Equipment Type
  • T2 Biosystems Inc Pipeline Products by Indication
  • T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
  • T2 Biosystems Inc, Key Facts
  • T2 Biosystems Inc, Major Products and Services
  • T2 Biosystems Inc Number of Pipeline Products by Development Stage
  • T2 Biosystems Inc Pipeline Products Summary by Development Stage
  • T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
  • T2 Biosystems Inc Ongoing Clinical Trials Summary
  • T2Carba Resistance+ - Product Status
  • T2Carba Resistance+ - Product Description
  • T2Dx - Cancer - Product Status
  • T2Dx - Cancer - Product Description
  • T2Dx - Cardiac - Product Status
  • T2Dx - Cardiac - Product Description
  • T2Endotoxin - Product Status
  • T2Endotoxin - Product Description
  • T2HemoStat - Product Status
  • T2HemoStat - Product Description
  • T2Lyme Panel - Product Status
  • T2Lyme Panel - Product Description
  • T2Lyme Panel - Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
  • T2MR Assay - Platelet Function Testing - Product Status
  • T2MR Assay - Platelet Function Testing - Product Description
  • T2Plex - Product Status
  • T2Plex - Product Description
  • T2Resistance Panel - Product Status
  • T2Resistance Panel - Product Description
  • T2Resistance Panel - Expansion - Product Status
  • T2Resistance Panel - Expansion - Product Description
  • T2 Biosystems Inc, Key Employees
  • T2 Biosystems Inc, Key Employee Biographies
  • T2 Biosystems Inc, Other Locations
  • Glossary
List of Figures
  • T2 Biosystems Inc Pipeline Products by Equipment Type
  • T2 Biosystems Inc Pipeline Products by Development Stage
  • T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
  • OpGen Inc
  • GenMark Diagnostics Inc
  • Diadexus Inc
  • Celula Inc
  • BioFire Diagnostics Inc
  • Becton Dickinson and Co
Note: Product cover images may vary from those shown
Adroll
adroll